.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
AstraZeneca
Farmers Insurance
Colorcon
US Department of Justice
QuintilesIMS
Dow
McKesson
Boehringer Ingelheim
US Army

Generated: November 22, 2017

DrugPatentWatch Database Preview

Atenolol - Generic Drug Details

« Back to Dashboard

What are the generic sources for atenolol and what is the scope of atenolol patent protection?

Atenolol
is the generic ingredient in five branded drugs marketed by Zydus Pharms Usa, Pliva, Alvogen Malta, Able, Sun Pharm Inds Inc, Aurobindo Pharma, Teva, Apothecon, Teva Pharms, Sandoz, Mylan, Nostrum Labs, Dava Pharms Inc, Unique Pharm Labs, Watson Labs, Watson Labs Teva, Northstar Hlthcare, Astrazeneca, Sun Pharm Inds, SCS, Ipca Labs Ltd, and Mutual Pharm, and is included in forty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-three drug master file entries for atenolol. Fifty-nine suppliers are listed for this compound.

Pharmacology for atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Able
ATENOLOL
atenolol
TABLET;ORAL076907-002Jul 30, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL073665-002Jul 2, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe
Northstar Hlthcare
ATENOLOL
atenolol
TABLET;ORAL078254-001Sep 25, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
ATENOLOL
atenolol
TABLET;ORAL073353-001Dec 27, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
ATENOLOL
atenolol
TABLET;ORAL074265-002Feb 28, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Able
ATENOLOL
atenolol
TABLET;ORAL076907-001Jul 30, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
ATENOLOL
atenolol
TABLET;ORAL074056-002Jan 18, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL072302-001May 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe
Northstar Hlthcare
ATENOLOL
atenolol
TABLET;ORAL078254-002Sep 25, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL073582-001Apr 29, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Teva
Express Scripts
Fuji
Johnson and Johnson
Cipla
Colorcon
Chubb
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot